Phospho-AMPA Receptor 2 (GluA2) (Tyr876) Antibody
Online Inquiry

Phospho-AMPA Receptor 2 (GluA2) (Tyr876) Antibody

INQUIRY

CAT. NO.: AMA-0813

Target Information
UniProt ID P42262
Product Details
Size 100 µL
Reactivity Rat
Storage Store at -20°C. Do not aliquot the antibody.
Purification Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Tyr876 of human AMPA Receptor 2 (GluA2). Antibodies are purified by protein A and peptide affinity chromatography.
Usage
Application WB
Product Usage Information Dilution Western Blotting (1:1000)
MW (Target) 100 kDa
Background
AMPA- (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), kainate-, and NMDA- (N-methyl-D-aspartate) receptors are the three main families of ionotropic glutamate-gated ion channels. AMPA receptors (AMPARs) are comprised of four subunits (GluR 1-4), which assemble as homo- or hetero-tetramers to mediate the majority of fast excitatory transmissions in the central nervous system. AMPARs are implicated in synapse formation, stabilization, and plasticity In contrast to GluR 2-containing AMPARs, AMPARs that lack GluR 2 are permeable to calcium Post-transcriptional modifications (alternative splicing, nuclear RNA editing) and post-translational modifications (glycosylation, phosphorylation) result in a very large number of permutations, fine-tuning the kinetic properties of AMPARs. Research studies have implicated activity changes in AMPARs in a variety of diseases including Alzheimer’s, amyotrophic lateral sclerosis (ALS), stroke, and epilepsySrc family tyrosine kinases phosphorylate the GluR 2 subunit of AMPA receptors at Tyr876, which increases the interaction with GRIP1/2 but not PICK1.

Our customers have direct access to our experts and give timely feedback to any online inquiries. If you are interested in our products, please contact us.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.